Successful management of severe allergic reactions to platelet transfusion with omalizumab: A case report.
Yeonjoo ChoiJa Min ByunInho KimJin Hyun ParkKi Hwan KimJin-Soo KimIn Sil ChoiMin-Suk YangHyunkyung ParkPublished in: Medicine (2022)
This case suggests that omalizumab is a good candidate for the management of severe allergic transfusion reactions.